Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Prescribing Practices Aprns Stimulants topic
No spam. Unsubscribe anytime.
Senate committee approves bill letting APRNs make therapeutic stimulant substitutions with physician notification
Summary
The Senate Public Health, Welfare and Labor Committee passed House Bill 1963 as amended to allow advanced practice registered nurses to substitute therapeutically equivalent stimulant medications if they notify the original prescribing physician; the committee adopted a sponsor-negotiated amendment clarifying the notice requirement.
State Senator Justin Boyd, Fort Smith, told the Senate Public Health, Welfare and Labor Committee that House Bill 1963, as amended, would allow an advanced practice registered nurse to substitute a therapeutically equivalent stimulant medication and would require notification to the physician who originally wrote the prescription.
The amendment, Boyd said, is “an agreed to amendment between the bill sponsor and the medical society to clarify that if a substitute is made under the bill as drafted, that notice would go back to the original physician.” The committee adopted that amendment by voice vote and then passed the bill as amended.
Why it matters: The bill changes who may make therapeutic substitutions for certain stimulant medications, such as Vyvanse, Focalin XR and Adderall XR. Under current practice described in the hearing, an advanced practice registered nurse (APRN) can write prescriptions for those stimulants only after a physician has written the initial prescription and the patient has been seen by a physician at least every six months; APRNs may continue ongoing prescriptions but not substitute formulations without this change.
Committee discussion and procedure: Senator Peyton asked whether APRNs in question operate independently or in physician clinics; testimony clarified APRNs can work either in independent clinics or inside physician clinics. Boyd explained the bill is intended to address situations such as prior authorization or formulary substitution where an APRN may need to change a specific stimulant formulation.
No members of the public signed up to speak for or against the bill. After final remarks from Boyd, the committee voted by voice vote to give HB1963 a do-pass recommendation as amended.
Clarifying details from the hearing: The bill text, as explained, permits therapeutic substitution of stimulant medications by an APRN but requires the APRN to notify the original prescribing physician if a substitution occurs. The current practice noted in the hearing requires an initial prescription by a physician and a physician visit at least every six months before APRNs continue stimulant prescriptions.
